JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB194357

Anti-Egr1 antibody [EPR15916]

3

(4 Reviews)

|

(16 Publications)

Rabbit Recombinant Monoclonal EGR1 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 16 publications.

View Alternative Names

KROX24, ZNF225, EGR1, Early growth response protein 1, EGR-1, AT225, Nerve growth factor-induced protein A, Transcription factor ETR103, Transcription factor Zif268, Zinc finger protein 225, Zinc finger protein Krox-24, NGFI-A

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-Egr1 antibody [EPR15916] (AB194357)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Egr1 antibody [EPR15916] (AB194357)

Confocal image showing nuclear and weakly cytoplasmic staining on Hela cells.

Immunocytometry/Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human cervix adenocarcinoma ) cells labeling Egr1 with ab194357 at 1/200 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution. The cells were co-stained with ab7291, a mouse anti-tubulin antibody (1/1000) using ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) as the secondary. Nuclei counterstained with DAPI (blue).

For negative control 1, ab194357 (1 : 200) was used, followed by (ab150120) anti-mouse secondary antibody at 1/1000 dilution. For negative control 2, (ab7291) mouse primary antibody (1/1000) was used followed by (ab150077) anti-rabbit secondary antibody at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Egr1 antibody [EPR15916] (AB194357)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Egr1 antibody [EPR15916] (AB194357)

Immunohistochemical analysis of paraffin-embedded human thyroid carcinoma tissue labeling Egr1 with ab194357 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Counter stained with hematoxylin.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-Egr1 antibody [EPR15916] (AB194357)
  • WB

Supplier Data

Western blot - Anti-Egr1 antibody [EPR15916] (AB194357)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Egr1 antibody [EPR15916] (ab194357) at 1/50000 dilution

All lanes:

293T treated with 20% FBS at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 57 kDa

Observed band size: 80 kDa

false

Western blot - Anti-Egr1 antibody [EPR15916] (AB194357)
  • WB

Lab

Western blot - Anti-Egr1 antibody [EPR15916] (AB194357)

False colour image of Western blot : Anti-Egr1 antibody [EPR15916] staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab194357 was shown to bind specifically to Egr1. A band was observed at 73 kDa in wild-type HeLa cell lysates with no signal observed at this size in EGR1 CRISPR-Cas9 edited cell line ab274929 (CRISPR-Cas9 edited cell lysate ab274987). The band observed in the CRISPR-Cas9 edited lysate lane below 73 kDa is likely to represent a truncated form of Egr1. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and EGR1 CRISPR-Cas9 edited HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

Lanes 1 - 4:

Western blot - Anti-Egr1 antibody [EPR15916] (ab194357) at 1/10000 dilution

Lanes 1 - 4:

Western blot - Anti-Egr1 antibody [EPR15916] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/egr1-antibody-epr15916-bsa-and-azide-free-ab232448'>ab232448</a>) at 1/10000 dilution

Lane 1:

Wild-type HeLa Vehicle Control TNF-a (0ng/mL, 1h) cell lysate at 20 µg

Lane 2:

Wild-type HeLa TNF-a (20ng/mL, 1h) cell lysate at 20 µg

Lane 3:

Western blot - Human EGR1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-egr1-knockout-hela-cell-line-ab274929'>ab274929</a>)

Lane 3:

Western blot - Human EGR1 knockout HeLa cell lysate (ab274987)

Lane 3:

EGR1 knockout HeLa Vehicle Control TNF-a (0ng/mL, 1h) cell lysate at 20 µg

Lane 4:

EGR1 knockout HeLa TNF-a (20ng/mL, 1h) cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 73 kDa

false

  • Carrier free

    Anti-Egr1 antibody [EPR15916] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR15916

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Egr1 also known as early growth response protein 1 is a zinc-finger transcription factor with a molecular weight of approximately 60 kDa. The Egr1 protein plays a significant role in gene expression regulation by binding to specific DNA sequences. This target is highly expressed in a variety of tissues including the brain heart and kidneys. In these tissues Egr1 regulates several cellular processes by activating or repressing target genes. Also Egr1 has monoclonal antibodies available for research purposes providing tools for detailed study in specific cellular contexts.
Biological function summary

Egr1 acts as an immediate-early response gene. It gets rapidly upregulated in response to growth factors stress signals and other extracellular stimuli. As part of the cellular signaling networks Egr1 interacts with other transcription factors to control the expression of genes involved in cell differentiation proliferation and apoptosis. It does not typically form part of a protein complex but may work in concert with other signaling molecules to influence diverse cellular pathways and maintain cellular homeostasis.

Pathways

Egr1 is involved in the MAPK/ERK and PI3K/AKT signaling pathways both key to regulating cellular growth and survival. It functions as a bridging factor that links extracellular signals to transcriptional changes within the nucleus. In the MAPK/ERK pathway Egr1 works alongside proteins like Ras and MEK to promote early gene transcription in response to mitogenic signals. In the PI3K/AKT pathway Egr1 can influence downstream targets reinforcing the pathway's mechanisms in determining cell fate.

Egr1 is linked to cancer and cardiovascular diseases. Abnormal Egr1 expression and activity have been observed in various cancers where it can act as an oncogene or tumor suppressor depending on the context. Abnormal interactions with proteins such as p53 may contribute to tumorigenesis. In cardiovascular diseases Egr1 influences pathological states by regulating genes associated with inflammation and vascular remodeling. The protein’s dysregulation plays a part in atherosclerosis connecting with inflammatory cytokines to promote disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcriptional regulator (PubMed : 20121949). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter region of target genes (By similarity). Binds double-stranded target DNA, irrespective of the cytosine methylation status (PubMed : 25258363, PubMed : 25999311). Regulates the transcription of numerous target genes, and thereby plays an important role in regulating the response to growth factors, DNA damage, and ischemia. Plays a role in the regulation of cell survival, proliferation and cell death. Activates expression of p53/TP53 and TGFB1, and thereby helps prevent tumor formation. Required for normal progress through mitosis and normal proliferation of hepatocytes after partial hepatectomy. Mediates responses to ischemia and hypoxia; regulates the expression of proteins such as IL1B and CXCL2 that are involved in inflammatory processes and development of tissue damage after ischemia. Regulates biosynthesis of luteinizing hormone (LHB) in the pituitary (By similarity). Regulates the amplitude of the expression rhythms of clock genes : BMAL1, PER2 and NR1D1 in the liver via the activation of PER1 (clock repressor) transcription. Regulates the rhythmic expression of core-clock gene BMAL1 in the suprachiasmatic nucleus (SCN) (By similarity).
See full target information EGR1

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Journal of Cancer 15:4577-4590 PubMed39006084

2024

EGR1 Promotes Erastin-induced Ferroptosis Through Activating Nrf2-HMOX1 Signaling Pathway in Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zhirong Lin,Zifei Liu,Zhilong Pan,Yunyi Zhang,Xinyu Yang,Yaxin Feng,Ruihua Zhang,Wenfeng Zeng,Chang Gong,Jianing Chen

Oncology letters 27:240 PubMed38623570

2024

Early growth response 1 regulates dual‑specificity protein phosphatase 1 and inhibits cell migration and invasion of tongue squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Longxun Zhou,Yuqun Shan,Jun Li,Min Li,Zhen Meng,Na Guo

Chinese medical journal 136:1177-1187 PubMed37083129

2023

Single-cell RNA sequencing reveals the transcriptomic landscape of kidneys in patients with ischemic acute kidney injury.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Tang,Peng Jin,Chanjuan Shen,Wei Lin,Leilin Yu,Xueling Hu,Ting Meng,Linlin Zhang,Ling Peng,Xiangcheng Xiao,Peter Eggenhuizen,Joshua D Ooi,Xueqin Wu,Xiang Ding,Yong Zhong

Journal of translational medicine 21:201 PubMed36932397

2023

EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanyang Wang,Cheng Qin,Bangbo Zhao,Zeru Li,Tianyu Li,Xiaoying Yang,Yutong Zhao,Weibin Wang

Cell death & disease 14:143 PubMed36805440

2023

Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Minbin Chen,Zhifei Li,Chengtao Gu,Hao Zheng,Yan Chen,Long Cheng

Frontiers in endocrinology 13:883658 PubMed35721731

2022

Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Ran Wei,Jingtao Qiao,Di Cui,Qi Pan,Lixin Guo

International journal of molecular sciences 23: PubMed35563324

2022

Early Growth Response 1 Strengthens Pol-III-Directed Transcription and Transformed Cell Proliferation by Controlling PTEN/AKT Signalling Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongyu Wu,Liyun Huang,Shasha Zhao,Juan Wang,Cheng Zhang,Xiaoye Song,Qiyue Chen,Jiannan Du,Deen Yu,Xiaomeng Sun,Yue Zhang,Wensheng Deng,Shihua Zhang,Huan Deng

iScience 24:103067 PubMed34541473

2021

A mechanism of cooling hot tumors: Lactate attenuates inflammation in dendritic cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hisashi Kanemaru,Yukari Mizukami,Akira Kaneko,Hidemi Tagawa,Toshihiro Kimura,Haruka Kuriyama,Soichiro Sawamura,Ikko Kajihara,Katsunari Makino,Azusa Miyashita,Jun Aoi,Takamitsu Makino,Shinichi Masuguchi,Satoshi Fukushima,Hironobu Ihn

Frontiers in oncology 11:699004 PubMed34497759

2021

miR-377-3p-Mediated EGR1 Downregulation Promotes B[a]P-Induced Lung Tumorigenesis by Wnt/Beta-Catenin Transduction.

Applications

Unspecified application

Species

Unspecified reactive species

Xinxin Ke,Lulu He,Runan Wang,Jing Shen,Zhengyang Wang,Yifei Shen,Longjiang Fan,Jimin Shao,Hongyan Qi

Aging 13:18515-18526 PubMed34292876

2021

Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion.

Applications

Unspecified application

Species

Unspecified reactive species

Najiao Hong,Zhirong Ye,Yongjun Lin,Wensen Liu,Na Xu,Yan Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com